NDC 68083-478

lincomycin hydrochloride

Lincomycin Hydrochloride

lincomycin hydrochloride is a Intramuscular; Intravenous; Subconjunctival Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Gland Pharma Limited. The primary component is Lincomycin Hydrochloride.

Product ID68083-478_084e1826-51be-4e48-aae4-b6affb80853f
NDC68083-478
Product TypeHuman Prescription Drug
Proprietary Namelincomycin hydrochloride
Generic NameLincomycin Hydrochloride
Dosage FormInjection, Solution
Route of AdministrationINTRAMUSCULAR; INTRAVENOUS; SUBCONJUNCTIVAL
Marketing Start Date2022-09-26
Marketing CategoryANDA /
Application NumberANDA215657
Labeler NameGland Pharma Limited
Substance NameLINCOMYCIN HYDROCHLORIDE
Active Ingredient Strength300 mg/mL
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 68083-478-01

1 VIAL in 1 CARTON (68083-478-01) > 2 mL in 1 VIAL
Marketing Start Date2022-09-26
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "lincomycin hydrochloride" or generic name "Lincomycin Hydrochloride"

NDCBrand NameGeneric Name
68083-478lincomycin hydrochloridelincomycin hydrochloride
68083-479Lincomycin hydrochloridelincomycin hydrochloride
0009-0555Lincocinlincomycin hydrochloride
0404-9901LINCOMYCINlincomycin hydrochloride
39822-0350Lincomycinlincomycin hydrochloride
39822-0353Lincomycinlincomycin hydrochloride
50090-4533Lincomycinlincomycin hydrochloride
52584-353LINCOMYCINlincomycin hydrochloride

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.